PL363157A1 - Hormonalna terapia zastępcza - Google Patents

Hormonalna terapia zastępcza

Info

Publication number: PL363157A1
Authority: PL; Poland
Prior art keywords: combination; replacement therapy; hormone replacement; medroxyprogesterone acetate; conjugated estrogens
Prior art date: 2000-03-20

Application number

PL01363157A

Other languages

English (en)

Other versions

PL201762B1 (pl

Inventor

James H. Pickar

Original Assignee

Wyeth

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-03-20

Filing date

2001-03-16

Publication date

2004-11-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26886279&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL363157(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2001-03-16 Application filed by Wyeth filed Critical Wyeth

2004-11-15 Publication of PL363157A1 publication Critical patent/PL363157A1/pl

2009-05-29 Publication of PL201762B1 publication Critical patent/PL201762B1/pl

Links

229940035811 conjugated estrogen Drugs 0.000 title 1
238000002657 hormone replacement therapy Methods 0.000 title 1
229960002985 medroxyprogesterone acetate Drugs 0.000 title 1
PSGAAPLEWMOORI-PEINSRQWSA-N medroxyprogesterone acetate Chemical compound C([C@@]12C)CC(=O)C=C1[C@@H](C)C[C@@H]1[C@@H]2CC[C@]2(C)[C@@](OC(C)=O)(C(C)=O)CC[C@H]21 PSGAAPLEWMOORI-PEINSRQWSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Neurology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Reproductive Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Virology (AREA)
Immunology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Gynecology & Obstetrics (AREA)
Molecular Biology (AREA)

PL363157A 2000-03-20 2001-03-16 Zastosowanie sprzężonych estrogenów i octanu medroksyprogesteronu do wytwarzania pakietów farmaceutycznych oraz kompozycja farmaceutyczna, jednostka dawkowania i pakiet zawierające sprzężone estrogeny i octan medroksyprogesteronu PL201762B1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US19063000P	2000-03-20	2000-03-20
US26860701P	2001-02-14	2001-02-14

Publications (2)

Publication Number	Publication Date
PL363157A1 true PL363157A1 (pl)	2004-11-15
PL201762B1 PL201762B1 (pl)	2009-05-29

Family

ID=26886279

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL363157A PL201762B1 (pl)	2000-03-20	2001-03-16	Zastosowanie sprzężonych estrogenów i octanu medroksyprogesteronu do wytwarzania pakietów farmaceutycznych oraz kompozycja farmaceutyczna, jednostka dawkowania i pakiet zawierające sprzężone estrogeny i octan medroksyprogesteronu

Country Status (30)

Country	Link
US (2)	US20010034340A1 (pl)
EP (1)	EP1265616B1 (pl)
JP (1)	JP2003527416A (pl)
KR (1)	KR100805648B1 (pl)
CN (1)	CN1239160C (pl)
AR (1)	AR031563A1 (pl)
AT (1)	ATE326227T1 (pl)
AU (2)	AU2001250034B2 (pl)
BG (1)	BG66075B1 (pl)
BR (1)	BR0109334A (pl)
CA (1)	CA2402983A1 (pl)
CY (1)	CY1105632T1 (pl)
CZ (1)	CZ20023162A3 (pl)
DE (1)	DE60119703T2 (pl)
DK (1)	DK1265616T3 (pl)
EA (1)	EA005592B1 (pl)
EE (1)	EE05129B1 (pl)
ES (1)	ES2261393T3 (pl)
HK (1)	HK1049449B (pl)
HR (1)	HRP20020837B1 (pl)
HU (1)	HUP0302093A3 (pl)
IL (1)	IL151512A0 (pl)
MX (1)	MXPA02009116A (pl)
NO (1)	NO326886B1 (pl)
NZ (1)	NZ521171A (pl)
PL (1)	PL201762B1 (pl)
PT (1)	PT1265616E (pl)
SK (1)	SK286169B6 (pl)
TW (1)	TWI271194B (pl)
WO (1)	WO2001070208A2 (pl)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20010044431A1 (en) *	2000-03-21	2001-11-22	Rodriguez Gustavo C.	Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6245819B1 (en)	2000-07-21	2001-06-12	Hormos Medical Oy, Ltd.	Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
EP1857110A3 (en) *	2001-03-16	2008-08-06	Wyeth	Hormone replacement therapy
NZ528373A (en) *	2001-03-16	2005-07-29	Wyeth Corp	Hormone replacement therapy
US8658627B2 (en)	2001-04-25	2014-02-25	The Regents Of The University Of California	Pregnancy hormone combination for treatment of autoimmune diseases
US20130203722A1 (en)	2006-09-26	2013-08-08	Rhonda R. Voskuhl	Estriol therapy for autoimmune and neurodegenerative disease and disorders
TWI252111B (en) *	2001-12-14	2006-04-01	Solvay Pharm Gmbh	Matrix film tablet with controlled release of a natural mixture of conjugated estrogens
TW200306196A (en) *	2002-04-03	2003-11-16	Wyeth Corp	Hormone replacement therapy
TW200306846A (en) *	2002-04-03	2003-12-01	Wyeth Corp	Hormone replacement therapy
MXPA04009671A (es) *	2002-04-03	2005-01-25	Barr Lab Inc	Terapia de reduccion escalonada con estrogenos.
TW200306851A (en) *	2002-04-29	2003-12-01	Wyeth Corp	Hormone replacement therapy
TW200400040A (en) *	2002-05-17	2004-01-01	Wyeth Corp	Hormone replacement therapy
KR100991157B1 (ko) *	2002-06-06	2010-11-02	호르모스 메디칼 리미티드	여성의 위축 억제 또는 위축관련 증상 치료 또는 예방 방법
US7192956B2 (en) *	2002-06-25	2007-03-20	Wyeth	Methods of treating hormone-related conditions using cyclothiocarbamate derivatives
US7488734B2 (en) *	2002-06-25	2009-02-10	Wyeth	Methods of treating hormone-related conditions using thio-oxindole derivatives
US8349819B2 (en)	2002-10-09	2013-01-08	Dr. Reddy's Laboratories New York, Inc.	Steroid extraction process from urine sources
CA2521471A1 (en) *	2003-04-11	2004-10-28	Barr Laboratories, Inc.	Methods of administering estrogens and progestins
US20060040904A1 (en) *	2004-08-17	2006-02-23	Ahmed Salah U	Vaginal cream compositions, kits thereof and methods of using thereof
AU2006330846A1 (en) *	2005-12-27	2007-07-05	Teva Women's Health, Inc.	Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof
US20070238713A1 (en) *	2006-04-05	2007-10-11	Wyeth	Methods for prevention and treatment of conditions arising from local estrogen deficiency
MX2009005724A (es) *	2006-11-29	2009-06-12	Wyeth Corp	Comprimidos bicapa de estrogenos/serm y estrogenos/progestina.
WO2008099060A2 (en) *	2007-02-14	2008-08-21	Hormos Medical Ltd	Methods for the preparation of fispemifene from ospemifene
MX2009008660A (es) *	2007-02-14	2009-10-13	Hormos Medical Ltd	Metodo para la preparacion de derivados de trifenilbuteno terapeuticamente valiosos.
KR100989093B1 (ko)	2008-01-18	2010-10-25	한화제약주식회사	생강나무 가지의 추출물을 포함하는 심혈관계 질환의 예방 및 치료용 조성물
US9734496B2 (en)	2009-05-29	2017-08-15	Paypal, Inc.	Trusted remote attestation agent (TRAA)
WO2011097571A2 (en) *	2010-02-08	2011-08-11	Prairie Pharmaceuticals, Llc	Methods for the use of progestogen as a glucocorticoid sensitizer
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US8633178B2 (en)	2011-11-23	2014-01-21	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
WO2014060639A1 (en)	2012-10-19	2014-04-24	Fermion Oy	A process for the preparation of ospemifene
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11224603B2 (en) *	2013-12-13	2022-01-18	Requis Pharmaceuticals, Inc.	Antihistamines in combination with a range of substances for improved health
US10369158B2 (en)	2014-04-28	2019-08-06	The Regents Of The University Of California	Pharmaceutical packaging for estriol therapy
EP3137087B1 (en)	2014-04-28	2023-09-06	The Regents of the University of California	Estrogen combination for treatment of multiple sclerosis
CA2947767A1 (en)	2014-05-22	2015-11-26	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10821117B2 (en)	2014-09-02	2020-11-03	The Regents Of The University Of California	Estrogen therapy for brain gray matter atrophy and associated disability
CA2962921A1 (en)	2014-09-29	2016-04-07	The Regents Of The University Of California	Compositions and methods for maintaining cognitive function
EP3277285B1 (en)	2015-03-30	2024-07-17	The Regents of the University of California	Estriol for reducing cortical gray matter atrophy
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
WO2017173071A1 (en)	2016-04-01	2017-10-05	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical composition
US20210386757A1 (en) *	2018-10-17	2021-12-16	Sarah S. Stadler	Methods of Treating Menopausal Symptoms Using Low Dose Progesterone
US11633405B2 (en)	2020-02-07	2023-04-25	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4826831A (en) *	1983-08-05	1989-05-02	Pre Jay Holdings Limited	Method of hormonal treatment for menopausal or post-menopausal disorders involving continuous administration of progestogens and estrogens
AU582540B2 (en) *	1983-08-05	1989-04-06	Pre Jay Holdings Ltd.	A method of hormonal treatment of perimenopausal, menopausal and post-menopausal disorders and multi-preparation pack therefor
NZ226316A (en) *	1987-09-24	1991-10-25	Jencap Research Ltd	Pharmaceutical contraceptive preparations and packages containing from 20-35 unit dosages comprising an estrogen and a progestin; the unit dosages having alternating estrogen and progestin dominance
NL9301562A (nl) *	1993-09-09	1995-04-03	Saturnus Ag	Preparaat voor substitutietherapie.
US5554601A (en) *	1993-11-05	1996-09-10	University Of Florida	Methods for neuroprotection
US5759577A (en) *	1995-01-17	1998-06-02	American Home Products Corporation	Controlled release of steroids from sugar coatings
US5547948A (en) *	1995-01-17	1996-08-20	American Home Products Corporation	Controlled release of steroids from sugar coatings

2001
- 2001-03-15 US US09/808,878 patent/US20010034340A1/en not_active Abandoned
- 2001-03-16 PL PL363157A patent/PL201762B1/pl not_active IP Right Cessation
- 2001-03-16 AT AT01923331T patent/ATE326227T1/de active
- 2001-03-16 SK SK1348-2002A patent/SK286169B6/sk not_active IP Right Cessation
- 2001-03-16 CZ CZ20023162A patent/CZ20023162A3/cs unknown
- 2001-03-16 MX MXPA02009116A patent/MXPA02009116A/es active IP Right Grant
- 2001-03-16 DK DK01923331T patent/DK1265616T3/da active
- 2001-03-16 HU HU0302093A patent/HUP0302093A3/hu unknown
- 2001-03-16 BR BR0109334-7A patent/BR0109334A/pt not_active Application Discontinuation
- 2001-03-16 EE EEP200200535A patent/EE05129B1/xx not_active IP Right Cessation
- 2001-03-16 HR HR20020837A patent/HRP20020837B1/xx not_active IP Right Cessation
- 2001-03-16 AU AU2001250034A patent/AU2001250034B2/en not_active Ceased
- 2001-03-16 EA EA200201000A patent/EA005592B1/ru not_active IP Right Cessation
- 2001-03-16 AU AU5003401A patent/AU5003401A/xx active Pending
- 2001-03-16 WO PCT/US2001/040302 patent/WO2001070208A2/en not_active Ceased
- 2001-03-16 KR KR1020027012420A patent/KR100805648B1/ko not_active Expired - Fee Related
- 2001-03-16 JP JP2001568406A patent/JP2003527416A/ja active Pending
- 2001-03-16 NZ NZ521171A patent/NZ521171A/en not_active IP Right Cessation
- 2001-03-16 DE DE60119703T patent/DE60119703T2/de not_active Expired - Lifetime
- 2001-03-16 IL IL15151201A patent/IL151512A0/xx not_active IP Right Cessation
- 2001-03-16 CN CNB018068235A patent/CN1239160C/zh not_active Expired - Fee Related
- 2001-03-16 ES ES01923331T patent/ES2261393T3/es not_active Expired - Lifetime
- 2001-03-16 HK HK03101651.5A patent/HK1049449B/en not_active IP Right Cessation
- 2001-03-16 CA CA002402983A patent/CA2402983A1/en not_active Abandoned
- 2001-03-16 EP EP01923331A patent/EP1265616B1/en not_active Expired - Lifetime
- 2001-03-16 PT PT01923331T patent/PT1265616E/pt unknown
- 2001-03-19 AR ARP010101273A patent/AR031563A1/es unknown
- 2001-03-19 TW TW090106349A patent/TWI271194B/zh not_active IP Right Cessation
2002
- 2002-09-12 BG BG107095A patent/BG66075B1/xx unknown
- 2002-09-19 NO NO20024478A patent/NO326886B1/no not_active IP Right Cessation
2006
- 2006-07-03 CY CY20061100910T patent/CY1105632T1/el unknown
2007
- 2007-11-06 US US11/979,633 patent/US20090005351A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DK1265616T3 (da)	2006-06-12
CN1239160C (zh)	2006-02-01
BG66075B1 (en)	2011-02-28
PT1265616E (pt)	2006-08-31
US20090005351A1 (en)	2009-01-01
KR100805648B1 (ko)	2008-02-26
EA200201000A1 (ru)	2003-02-27
KR20020084230A (ko)	2002-11-04
AU2001250034B2 (en)	2005-03-24
HUP0302093A2 (hu)	2003-10-28
ES2261393T3 (es)	2006-11-16
US20010034340A1 (en)	2001-10-25
EE05129B1 (et)	2009-02-16
HRP20020837A2 (en)	2004-02-29
HUP0302093A3 (en)	2010-03-29
EE200200535A (et)	2004-04-15
ATE326227T1 (de)	2006-06-15
EP1265616B1 (en)	2006-05-17
CN1418102A (zh)	2003-05-14
NO326886B1 (no)	2009-03-16
WO2001070208A2 (en)	2001-09-27
HRP20020837B1 (hr)	2007-08-31
HK1049449A1 (en)	2003-05-16
DE60119703T2 (de)	2006-10-19
NZ521171A (en)	2004-09-24
SK286169B6 (sk)	2008-04-07
SK13482002A3 (sk)	2003-02-04
BR0109334A (pt)	2002-12-24
JP2003527416A (ja)	2003-09-16
CZ20023162A3 (cs)	2003-03-12
PL201762B1 (pl)	2009-05-29
HK1049449B (en)	2006-07-28
BG107095A (bg)	2003-05-30
EP1265616A2 (en)	2002-12-18
CA2402983A1 (en)	2001-09-27
AU5003401A (en)	2001-10-03
WO2001070208A3 (en)	2002-04-25
CY1105632T1 (el)	2010-12-22
NO20024478D0 (no)	2002-09-19
AR031563A1 (es)	2003-09-24
MXPA02009116A (es)	2003-03-12
IL151512A0 (en)	2003-04-10
NO20024478L (no)	2002-09-19
TWI271194B (en)	2007-01-21
DE60119703D1 (de)	2006-06-22
EA005592B1 (ru)	2005-04-28

Legal Events

Date	Code	Title	Description
2013-05-31	LAPS	Decisions on the lapse of the protection rights	Effective date: 20120316

Publication	Publication Date	Title
IL151512A0 (en)	2003-04-10	Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
HUP0204291A3 (en)	2003-05-28	Use of composition containing estrogen and drospirenone for hormone replacement therapy
AU3947902A (en)	2002-06-03	Therapeutic agents and methods of use thereof for the modulation of angiogenesis
AU2001273074A1 (en)	2002-01-21	Combinations of ssri and estrogenic agents
HUP0400646A3 (en)	2012-08-28	Steroid hormone-compositions and processes for their preparation
AU2001271785A1 (en)	2002-01-21	Combinations of statins, estrogenic agents and optionally estrogens
PL368730A1 (pl)	2005-04-04	Preformulacja do tabletkowania naturalnych mieszanin sprzężonych estrogenów
HU229606B1 (en)	2014-02-28	Novel combination of loteprednol and antihistamines
AU4134101A (en)	2001-05-30	Hormone receptor functional entities and methods of their use
HUP0103072A3 (en)	2003-07-28	Use of growth hormone secretagogues
IL147253A0 (en)	2002-08-14	Growth hormone formulations
IL149715A0 (en)	2002-11-10	MICROBIAL 9α-HYDROXYLATION OF STEROIDS
HRP20020893A2 (en)	2004-02-29	Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
PL332610A1 (en)	1999-09-27	Hormonal preparation consisting of an oestrogen compound and of a progesterone compound
IL151589A0 (en)	2003-04-10	New combination of a betablocker and a cholestrol-lowering agent
AP2002002475A0 (en)	2002-06-30	Hormonal composition based on a progesterone and an oestrogen and use thereof
AU2001255013A1 (en)	2001-12-03	Combination of growth hormone secretagogues and antidepressants
AU2002217841A1 (en)	2002-05-15	Neuroactive steroid derivatives and methods of use
SI1265616T1 (sl)	2006-08-31	Hormonsko nadomestno zdravljenje z uporabo kombinacije konjugiranih estrogenov in medroksiprogesteron-acetata
IL151523A0 (en)	2003-04-10	Use of avocado-soybean unsaponifiable preparations
PL353487A1 (pl)	2003-11-17	Nowa kombinacja loteprednolu i agonistów beta2 adrenoreceptora
NO20006381D0 (no)	2000-12-14	Terapeutiske kombinasjoner av (selektive) östrogenreseptormodulatorer (SERM) og veksthormonsekresjonsmidler
AU4825200A (en)	2000-11-21	Oral steroidal hormone compositions and methods of use
AU2002304816A1 (en)	2002-12-16	Modulation of steroid hormone uptake
IL156655A0 (en)	2004-01-04	Hormone replacement therapy method and its administration form